Company news

AnGes. Inc. news in 2025

AnGes. Inc.'s news releases, calls and decks from 2025, newest first.

View company

Notice of Joint Research Agreement on Zokinvy

December 9, 2025

Vasomune Therapeutics Inc., and AnGes Inc., Expand the Scope of the Co-Development Agreement to Target Additional Indications

November 25, 2025

AnGes.: Consolidated Financial Report for the Third Quarter 2025

November 7, 2025

Notice Regarding Revision of Consolidated Earnings Forecast for the Fiscal Year Ending December 2025

October 27, 2025

Notice of Expansion of License Agreement Scope by Our Subsidiary

September 4, 2025

Notice Regarding the Initiation of a New Clinical Study for the Jointly Developed Tie2 Receptor Agonist (AV-001)

September 3, 2025

ACRL Announcement on Commencement of Biomarker Testing for Mucopolysaccharidosis

August 26, 2025

HGF Gene Therapy Product: AnGes and Boehringer Enter Manufacturing Collaboration

August 20, 2025

AnGes.: Consolidated Financial Report for the Second Quarter 2025

August 8, 2025

Decks in 2025